FDA Product Code QDK: Integrated Continuous Glucose Monitoring System For Non-intensive Diabetes Management
An Integrated Continuous Glucose Monitoring System For Non-intensive Diabetes Management Is Intended To Replace Finger Stick Blood Glucose Testing For Diabetes Treatment Decisions In Persons With Diabetes Who Do Not Have Significant Risk Of Severe Hypoglycemia. The Device Also Aids In The Detection Of Episodes Of Hyperglycemia And Hypoglycemia, Facilitating Long-term Therapy Adjustments. The Device Is Also Intended To Autonomously Communicate With Digitally Connected Devices. The Device Can Be Used Alone Or In Conjunction With These Digitally Connected Devices Or Services For The Purpose Of Managing Diabetes.
Leading manufacturers include Dexcom, Inc..
4
Total
4
Cleared
113d
Avg days
2018
Since
FDA 510(k) Cleared Integrated Continuous Glucose Monitoring System For Non-intensive Diabetes Management Devices (Product Code QDK)
4 devices
Cleared
Aug 17, 2021
Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System
Dexcom, Inc.
Chemistry
308d
Cleared
Jan 29, 2020
Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System
Dexcom, Inc.
Chemistry
30d
Cleared
Oct 25, 2019
Dexcom G6 Glucose Program Continuous Glucose Monitoring (GCM) System
Dexcom, Inc.
Chemistry
25d
Cleared
Oct 26, 2018
Dexcom G6 Glucose Program Continuous Glucose Monitoring System
Dexcom, Inc.
Chemistry
88d